VENTAVIS Side Effects

6608460-2 | Oedema Peripheral, Pulmonary Oedema
on Feb 04, 2010 Female patient from UNITED STATES , 70 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Ventavis (View Usage). Patient experienced the following unwanted or unexpected effects: oedema peripheral, pulmonary oedema. Ventavis dosage: 10 Mcg Solution, Respiratory. During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), METOLAZONE (View Metolazone Review and Metolazone Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

6608453-5 | Anoxic Encephalopathy, Cardiac Arrest, Disease Progression, Hypokalaemia, Hypotension, Myocardial Infarction, Myocardial Ischaemia, Palpitations, Pulmonary Hypertension
Patient was taking Ventavis (View Usage). Patient had the following side effects: anoxic encephalopathy, cardiac arrest (What is cardiac arrest?), disease progression, hypokalaemia, hypotension, myocardial infarction, myocardial ischaemia, palpitations, pulmonary hypertension (What is pulmonary hypertension?) on Feb 08, 2010 from UNITED STATES Additional patient health information: Female patient , 77 years of age, was diagnosed with pulmonary arterial hypertension and. Ventavis dosage: Respiratory. During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ). Patient was hospitalized.

6608345-1 | Bladder Neoplasm
Adverse event was reported on Feb 15, 2010 by a Male patient taking Ventavis (View Usage) (Dosage: ) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 72 years of age, After Ventavis was administered, patient had the following side effects: bladder neoplasm. Patient was hospitalized.

6608341-4 | Chest Discomfort, Chest Pain, Paraesthesia
on Feb 10, 2010 Female patient from UNITED STATES , 61 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Ventavis (View Usage). Patient experienced the following unwanted or unexpected effects: chest discomfort, chest pain (What is chest pain?), paraesthesia. Ventavis dosage: 5 Ug, 6-9 X Per Day, Respiratory; 2.5 Ug, Respiratoryug. During the same period patient was treated with TRACLEER (View Tracleer Review and Tracleer Label ).


6600439-X | Chills, Nausea, Tremor, Vertigo
on Feb 23, 2010 Female patient from GERMANY , 59 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and was treated with Ventavis (View Usage). Patient had the following side effects: chills, nausea (What is nausea?), tremor, vertigo. Ventavis dosage: Unk, 6 X Day, Respiratory. During the same period patient was treated with TRACLEER (View Tracleer Review and Tracleer Label ), COUMADIN (View Coumadin Review and Coumadin Label ).

6600438-8 | Adrenal Insufficiency, Condition Aggravated, Pulmonary Hypertension, Renal Failure
Patient was taking Ventavis (View Usage). After Ventavis was administered, patient had the following side effects: adrenal insufficiency, condition aggravated, pulmonary hypertension (What is pulmonary hypertension?), renal failure on Feb 23, 2010 from GERMANY Additional patient health information: Female patient , 36 years of age, was diagnosed with pulmonary hypertension (What is pulmonary hypertension?) and. Ventavis dosage: Unk, 3x Day, Respiratory. Patient was hospitalized.

6595296-4 | Pneumonia
Adverse event was reported on Jan 25, 2010 by a Male patient taking Ventavis (View Usage) (Dosage: Respiratory) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 81 years of age, Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?). During the same period patient was treated with TRACLEER (Oral) (View Tracleer Review and Tracleer Label ).

6595256-3 |
on Jan 25, 2010 Male patient from UNITED STATES , 66 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Ventavis (View Usage). . Ventavis dosage: Respiratory. During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), CALCIUM CHANNEL BLOCKERS (View Calcium Channel Blockers Review and Calcium Channel Blockers Label ).

6590351-7 | Condition Aggravated, Pulmonary Arterial Hypertension
on Jan 22, 2010 Female patient from UNITED STATES , 76 years of age, weighting 136.0 lb, was diagnosed with pulmonary arterial hypertension and was treated with Ventavis (View Usage). After Ventavis was administered, patient had the following side effects: condition aggravated, pulmonary arterial hypertension. Ventavis dosage: 5 Ug, Q3hrs, Respiratory. Patient was hospitalized.

6589323-8 | Anaemia, Bradycardia, Cardiac Arrest, Cardiac Failure, Cardiovascular Insufficiency, Condition Aggravated, Dyspnoea, Epistaxis, International Normalised Ratio Increased
Patient was taking Ventavis (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, bradycardia, cardiac arrest (What is cardiac arrest?), cardiac failure, cardiovascular insufficiency, condition aggravated, dyspnoea, epistaxis, international normalised ratio increased on Jan 26, 2010 from GERMANY Additional patient health information: Male patient , 78 years of age, was diagnosed with pulmonary arterial hypertension and. Ventavis dosage: 5 Ug, 6 X Day, Respiratory. During the same period patient was treated with TRACLEER (View Tracleer Review and Tracleer Label ), SILDENAFIL CITRATE (View Sildenafil Citrate Review and Sildenafil Citrate Label ), TOREM (TORASEMIDE) (View Torem (torasemide) Review and Torem (torasemide) Label ), MARCUMAR (View Marcumar Review and Marcumar Label ), OXYGEN (OXYGEN) (View Oxygen (oxygen) Review and Oxygen (oxygen) Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), BICALUTAMIDE (View Bicalutamide Review and Bicalutamide Label ). Patient was hospitalized.

6589016-7 | Circulatory Collapse
Adverse event was reported on Jan 24, 2010 by a Female patient taking Ventavis (View Usage) (Dosage: 2.5 Ug, Respiratory) was diagnosed with pulmonary arterial hypertension and. Location: GERMANY , 21 years of age, Patient had the following side effects: circulatory collapse. Patient was hospitalized.

6575279-0 |
on Jan 20, 2010 Female patient from UNITED STATES , 84 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Ventavis (View Usage). . Ventavis dosage: Respiratory.

6575271-6 |
on Jan 19, 2010 Male patient from UNITED STATES , 86 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Ventavis (View Usage). . Ventavis dosage: Respiratory. During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

6575117-6 | Intestinal Haemorrhage, Muscle Haemorrhage
Patient was taking Ventavis (View Usage). Patient had the following side effects: intestinal haemorrhage, muscle haemorrhage on Jan 18, 2010 from GERMANY Additional patient health information: Female patient , 53 years of age, was diagnosed with pulmonary arterial hypertension and. Ventavis dosage: Respiratory. During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

6572044-5 |
Adverse event was reported on Jan 18, 2010 by a Male patient taking Ventavis (View Usage) (Dosage: Respiratory) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 46 years of age, . During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ).

6567970-7 |
on Jan 14, 2010 Female patient from UNITED STATES , 58 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Ventavis (View Usage). . Ventavis dosage: Respiratory. During the same period patient was treated with TRACLEER (Oral) (View Tracleer Review and Tracleer Label ), REVATIO (View Revatio Review and Revatio Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

6552754-6 | Dyspnoea, No Therapeutic Response
on Jan 07, 2010 Female patient from UNITED STATES , 67 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Ventavis (View Usage). Patient had the following side effects: dyspnoea, no therapeutic response. Ventavis dosage: Respiratory. During the same period patient was treated with TRACLEER (Oral) (View Tracleer Review and Tracleer Label ).

6552742-X | No Therapeutic Response
Patient was taking Ventavis (View Usage). After Ventavis was administered, patient had the following side effects: no therapeutic response on Jan 06, 2010 from UNITED STATES Additional patient health information: Female patient , 84 years of age, was diagnosed with pulmonary arterial hypertension and. Ventavis dosage: Respiratory.

6552061-1 |
Adverse event was reported on Jan 07, 2010 by a Female patient taking Ventavis (View Usage) (Dosage: Respiratory) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 86 years of age, . During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ).

6552059-3 | Oedema Peripheral
on Jan 06, 2010 Male patient from UNITED STATES , 35 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Ventavis (View Usage). Patient had the following side effects: oedema peripheral. Ventavis dosage: Respiratory. During the same period patient was treated with TRACLEER (Oral) (View Tracleer Review and Tracleer Label ), REVATIO (View Revatio Review and Revatio Label ).

6546681-8 |
on Jan 04, 2010 Female patient from UNITED STATES , 73 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Ventavis (View Usage). . Ventavis dosage: Respiratory.

6538148-8 | Asthma, Cardiopulmonary Failure
Patient was taking Ventavis (View Usage). Patient experienced the following unwanted or unexpected effects: asthma (What is asthma?), cardiopulmonary failure on Dec 31, 2009 from GERMANY Additional patient health information: Female patient , 21 years of age, was diagnosed with pulmonary arterial hypertension and. Ventavis dosage: 2.5 Ug, Respiratory. Patient was hospitalized.

6536840-2 | Disease Progression, Off Label Use, Pulmonary Arterial Hypertension, Respiratory Failure
Adverse event was reported on Dec 21, 2009 by a Male patient taking Ventavis (View Usage) (Dosage: 6 X Day, Respiratory) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 78 years of age, Patient had the following side effects: disease progression, off label use, pulmonary arterial hypertension, respiratory failure. During the same period patient was treated with SILDENAFIL (View Sildenafil Review and Sildenafil Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

6528817-8 | Bronchospasm, Laryngospasm
on Dec 14, 2009 Female patient from ITALY , 67 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Ventavis (View Usage). After Ventavis was administered, patient had the following side effects: bronchospasm, laryngospasm. Ventavis dosage: 2.5 Ug, 1 Dose, Respiratory. During the same period patient was treated with TORSEMIDE (View Torsemide Review and Torsemide Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), ESOMEPRAZOLE SODIUM (ESOMEPRAZOLE SODIUM) (View Esomeprazole Sodium (esomeprazole Sodium) Review and Esomeprazole Sodium (esomeprazole Sodium) Label ).

6528816-6 | Bronchitis, Bronchopulmonary Aspergillosis, Chronic Obstructive Pulmonary Disease, Condition Aggravated, Diarrhoea, Haemoptysis, Lung Infection Pseudomonal, Major Depression, Staphylococcal Infection
on Dec 13, 2009 Female patient from GERMANY , 64 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Ventavis (View Usage). Patient experienced the following unwanted or unexpected effects: bronchitis (What is bronchitis?), bronchopulmonary aspergillosis, chronic obstructive pulmonary disease, condition aggravated, diarrhoea, haemoptysis, lung infection pseudomonal, major depression, staphylococcal infection (What is staphylococcal infection?). Ventavis dosage: 5 Ug, 6xday, Respiratory. During the same period patient was treated with MARCUMAR (View Marcumar Review and Marcumar Label ), OXYGEN (OXYGEN) (View Oxygen (oxygen) Review and Oxygen (oxygen) Label ), SILDENAFIL (View Sildenafil Review and Sildenafil Label ), CITALOPRAM (CITALOPRAM HYDROCHLORIDE) (View Citalopram (citalopram Hydrochloride) Review and Citalopram (citalopram Hydrochloride) Label ), PIPERACILLIN W/TAZOBACTAM (TAZOBACTAM, PIPERACILLIN) (View Piperacillin W/tazobactam (tazobactam, Piperacillin) Review and Piperacillin W/tazobactam (tazobactam, Piperacillin) Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ). Patient was hospitalized.

6526419-0 | Bradycardia, Hyperhidrosis, Hypotension, Liver Disorder, Liver Function Test Abnormal, Palpitations
Patient was taking Ventavis (View Usage). Patient had the following side effects: bradycardia, hyperhidrosis, hypotension, liver disorder, liver function test abnormal, palpitations on Dec 14, 2009 from UNITED STATES Additional patient health information: Female patient , 77 years of age, weighting 172.0 lb, was diagnosed with pulmonary arterial hypertension and. Ventavis dosage: 5 Ug, Respiratory; 2.5 Ug, Respiratory. During the same period patient was treated with TRACLEER (View Tracleer Review and Tracleer Label ), CALCIUM CHANNEL BLOCKERS (View Calcium Channel Blockers Review and Calcium Channel Blockers Label ), COUMADIN (View Coumadin Review and Coumadin Label ).

6521863-X |
Adverse event was reported on Dec 14, 2009 by a Female patient taking Ventavis (View Usage) (Dosage: Respiratory) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 56 years of age, . During the same period patient was treated with TRACLEER (View Tracleer Review and Tracleer Label ), REVATIO (SILENAFIL CITRATE) (View Revatio (silenafil Citrate) Review and Revatio (silenafil Citrate) Label ).

6454607-0 | Dyspnoea, No Therapeutic Response
on Nov 17, 2009 Male patient from UNITED STATES , 81 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Ventavis (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, no therapeutic response. Ventavis dosage: Respiratory. During the same period patient was treated with TRACLEER (Oral) (View Tracleer Review and Tracleer Label ).

6454605-7 | Anaemia, Contact Stomatitis, Gingival Bleeding, International Normalised Ratio Increased, Platelet Count Decreased, Rectal Haemorrhage
on Nov 03, 2009 Female patient from UNITED STATES , 75 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Ventavis (View Usage). Patient had the following side effects: anaemia, contact stomatitis, gingival bleeding, international normalised ratio increased, platelet count decreased, rectal haemorrhage. Ventavis dosage: 5 Ug, 6xday, Respiratory; 2.5 Ug, 6xday, Respiratory; 5 Ug, Respiratory. During the same period patient was treated with TRACLEER (View Tracleer Review and Tracleer Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), FUROSEMIDE (FUROSEMIDE SODIUM) (View Furosemide (furosemide Sodium) Review and Furosemide (furosemide Sodium) Label ), AUGMENTIN (CLAVULANIC ACID, AMOXICILLIN) (View Augmentin (clavulanic Acid, Amoxicillin) Review and Augmentin (clavulanic Acid, Amoxicillin) Label ). Patient was hospitalized.

6453934-0 | Bronchitis, Diarrhoea, Heart Rate Irregular, Nausea, Pneumonia, Pneumonitis, Pyrexia
Patient was taking Ventavis (View Usage). After Ventavis was administered, patient had the following side effects: bronchitis (What is bronchitis?), diarrhoea, heart rate irregular, nausea (What is nausea?), pneumonia (What is pneumonia?), pneumonitis, pyrexia on Nov 05, 2009 from UNITED STATES Additional patient health information: Male patient , 54 years of age, was diagnosed with pulmonary arterial hypertension and. Ventavis dosage: 2 Doses, Respiratory. During the same period patient was treated with SILDENAFIL (View Sildenafil Review and Sildenafil Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

6450165-5 | Haemoptysis
Adverse event was reported on Jan 21, 2009 by a Female patient taking Ventavis (View Usage) (Dosage: Respiratory) . Location: UNITED STATES , 63 years of age, Patient experienced the following unwanted or unexpected effects: haemoptysis. During the same period patient was treated with EPOPROSTENOL (View Epoprostenol Review and Epoprostenol Label ). Patient was hospitalized.

6450154-0 | Chest Pain, Dyspnoea, Headache
on Apr 15, 2009 Female patient from UNITED STATES , 32 years of age, weighting 138.0 lb, was diagnosed with pulmonary arterial hypertension and was treated with Ventavis (View Usage). Patient had the following side effects: chest pain (What is chest pain?), dyspnoea, headache (What is headache?). Ventavis dosage: 5 Ug, Respiratory : 2.5 Ug, Respiratory. During the same period patient was treated with TRACLEER (Mg, Oral) (View Tracleer Review and Tracleer Label ), PLAQUENIL (View Plaquenil Review and Plaquenil Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), LASIX (View Lasix Review and Lasix Label ), POTASSIUM (View Potassium Review and Potassium Label ), PROCARDIA XL (View Procardia Xl Review and Procardia Xl Label ). Patient was hospitalized.

6450148-5 | Cough, Fall, Fracture, Hip Fracture, Hypotension, Jaw Fracture, Laceration, Syncope
on Apr 14, 2009 Male patient from UNITED STATES , 75 years of age, was treated with Ventavis (View Usage). After Ventavis was administered, patient had the following side effects: cough, fall (What is fall?), fracture (What is fracture?), hip fracture, hypotension, jaw fracture, laceration, syncope. Ventavis dosage: Respiratory. Patient was hospitalized.

6450143-6 | Pulmonary Hypertension
Patient was taking Ventavis (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary hypertension (What is pulmonary hypertension?) on Oct 15, 2009 from UNITED STATES Additional patient health information: Male patient , 81 years of age, was diagnosed with pulmonary arterial hypertension and. Ventavis dosage: Respiratory.

6442912-3 | Bronchospasm, Laryngospasm
Adverse event was reported on Nov 05, 2009 by a Female patient taking Ventavis (View Usage) (Dosage: 2.5 Ug, 1 Dose, Respiratory) was diagnosed with pulmonary arterial hypertension and. Location: ITALY , 67 years of age, Patient had the following side effects: bronchospasm, laryngospasm. During the same period patient was treated with TORSEMIDE (View Torsemide Review and Torsemide Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), ESOMEPRAZOLE SODIUM (ESOMEPRAZOLE SODIUM) (View Esomeprazole Sodium (esomeprazole Sodium) Review and Esomeprazole Sodium (esomeprazole Sodium) Label ).

6442893-2 |
on Nov 05, 2009 Female patient from UNITED KINGDOM , 60 years of age, was treated with Ventavis (View Usage). . Ventavis dosage: Respiratory.

6442400-4 |
on Nov 05, 2009 Female patient from GERMANY , 71 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Ventavis (View Usage). . Ventavis dosage: Respiratory.

6431684-4 | Coma, Disease Progression, Hypotension, Pulmonary Arterial Hypertension
Patient was taking Ventavis (View Usage). Patient had the following side effects: coma, disease progression, hypotension, pulmonary arterial hypertension on Oct 27, 2009 from GERMANY Additional patient health information: Female patient , 40 years of age, was diagnosed with pulmonary arterial hypertension and. Ventavis dosage: Respiratory. Patient was hospitalized.

6428837-8 | Headache, Tremor, Vomiting
Adverse event was reported on Oct 20, 2009 by a Female patient taking Ventavis (View Usage) (Dosage: 2.5 Ug, Respiratory; 2.5 Ug, 6x/day,respiratory) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 74 years of age, After Ventavis was administered, patient had the following side effects: headache (What is headache?), tremor, vomiting.

6428007-3 | Abdominal Pain Upper, Bedridden, Dysgeusia, Headache, Throat Irritation
on Oct 22, 2009 Female patient from GERMANY , 78 years of age, was treated with Ventavis (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, bedridden, dysgeusia, headache (What is headache?), throat irritation. Ventavis dosage: 5 Ug, Qid, Respiratory.

6426949-6 | Pulmonary Hypertension
on Oct 15, 2009 Male patient from UNITED STATES , 81 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Ventavis (View Usage). Patient had the following side effects: pulmonary hypertension (What is pulmonary hypertension?). Ventavis dosage: Respiratory.

6416924-X |
Patient was taking Ventavis (View Usage). on Oct 14, 2009 from GERMANY Additional patient health information: Female patient , 34 years of age, . Ventavis dosage: Respiratory.

6416923-8 |
Adverse event was reported on Oct 14, 2009 by a Female patient taking Ventavis (View Usage) (Dosage: Respiratory) . Location: GERMANY , 75 years of age, .

6416922-6 |
on Oct 14, 2009 Female patient from GERMANY , 68 years of age, was treated with Ventavis (View Usage). . Ventavis dosage: Respiratory.

6408846-5 | Disease Progression, Hypoxia, Pain In Extremity, Pulmonary Hypertension, Vasculitic Rash
on Oct 05, 2009 Female patient from NEW ZEALAND , 59 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Ventavis (View Usage). After Ventavis was administered, patient had the following side effects: disease progression, hypoxia, pain in extremity, pulmonary hypertension (What is pulmonary hypertension?), vasculitic rash. Ventavis dosage: 20 Ug, Q4h, Respiratory; 15 Ug, 3 X Day, Respiratory; 20 Ug, 3x/day, Respiratory. During the same period patient was treated with SILDENAFIL CITRATE (View Sildenafil Citrate Review and Sildenafil Citrate Label ), OXYGEN (OXYGEN) (View Oxygen (oxygen) Review and Oxygen (oxygen) Label ), DIURETICS (View Diuretics Review and Diuretics Label ). Patient was hospitalized.

6402376-2 | Cardiac Failure, Renal Failure
Patient was taking Ventavis (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure, renal failure on Sep 28, 2009 from UNITED STATES Additional patient health information: Female patient , 79 years of age, was diagnosed with pulmonary arterial hypertension and. Ventavis dosage: Respiratory. During the same period patient was treated with TRACLEER (Unk, Unk, Oral) (View Tracleer Review and Tracleer Label ).

6399209-X | Cyanosis, Purulence, Toe Amputation
Adverse event was reported on Sep 30, 2009 by a Female patient taking Ventavis (View Usage) (Dosage: Intravenous) was diagnosed with raynaud's phenomenon and. Location: FRANCE , 66 years of age, Patient had the following side effects: cyanosis, purulence, toe amputation.

6399208-8 | Arteriospasm Coronary
on Sep 30, 2009 Male patient from FRANCE , 40 years of age, was diagnosed with thromboangiitis obliterans and was treated with Ventavis (View Usage). After Ventavis was administered, patient had the following side effects: arteriospasm coronary. Ventavis dosage: Intravenous.

6390540-0 | Angina Pectoris, Arteriospasm Coronary
on Sep 18, 2009 Male patient from FRANCE , 40 years of age, was diagnosed with thromboangiitis obliterans and was treated with Ventavis (View Usage). Patient experienced the following unwanted or unexpected effects: angina pectoris, arteriospasm coronary. Ventavis dosage: Intravenous.

6389543-1 | Hot Flush, Hypersensitivity, Oedema Peripheral, Pruritus, Swelling Face
Patient was taking Ventavis (View Usage). Patient had the following side effects: hot flush, hypersensitivity, oedema peripheral, pruritus, swelling face on Sep 17, 2009 from UNITED STATES Additional patient health information: Female patient , 61 years of age, was diagnosed with pulmonary arterial hypertension and. Ventavis dosage: Respiratory. During the same period patient was treated with TRACLEER (View Tracleer Review and Tracleer Label ), REVATIO (View Revatio Review and Revatio Label ).